Novo Nordisk
Pharma

ADA: Novo's Wegovy pill crosses hefty 3M prescription threshold

The scope of the pill’s popularity and its potential to reach new obesity patients are difficult to deny after a new launch update.
Fraiser Kansteiner Jun 8, 2026 11:38am
Hympavzi

FDA signs off on pediatric use of Pfizer's hemophilia treatment

Jun 8, 2026 10:32am
Amgen American Diabetes Association ADA ADA2026

ADA: Amgen talks Repatha, GLP-1 hurdles as obesity plan advances

Jun 7, 2026 9:13pm
Takeda

Takeda swings to loss for '25 with hefty jury verdict

Jun 5, 2026 11:30am
mifepristone

FDA is moving forward with abortion pill safety study: WSJ

Jun 5, 2026 11:06am
The Top Line

Behind the headlines of ASCO 2026

Jun 5, 2026 9:38am
More News

Regulatory tracker: AbbVie's Elahere cleared for use in England

Jun 5, 2026 9:25am
Fierce Biotech

At CNPV hearing, industry support meets ‘concern’ from experts

Jun 5, 2026 5:00am

In a big win for generics drugmakers, SCOTUS sides with Hikma

Jun 4, 2026 3:11pm

Patient deaths raise questions about ADC's cancer drug Zynlonta

Jun 4, 2026 11:38am